Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 4, 2009, Pages 373-378

  He, Lingmin ^a   Ta, Christopher N ^a   Hu, Nan ^a   Sinnar, Shamim ^a   Miño De Kaspar, Herminia ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; POVIDONE IODINE; THIOGLYCOLIC ACID;

ADULT; AGED; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CATARACT EXTRACTION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTERIOR EYE SEGMENT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; AZA COMPOUNDS; COLONY COUNT, MICROBIAL; CONJUNCTIVA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; POVIDONE-IODINE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; QUINOLINES; SINGLE-BLIND METHOD; STAPHYLOCOCCUS; YOUNG ADULT;

EID: 68549096119     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0102     Document Type: Article

References (23)

1. Aaberg, T.M., Jr., Flynn, H.W., Jr., Schiffman, J., et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 105:1004-1010, 1998. (Pubitemid 28268323)
2. Lemley, C.A., and Han, D.P. ENDOPHTHALMITIS: A review of current evaluation and management. Retina. 27:662-680, 2007.
3. Ta, C.N., Chang, R.T., Singh, K., et al. Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology. 110:1946-1951, 2003.
4. Speaker, M.G., Milch, F.A., Shah, M.K., et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 98:639-649; discussion 650, 1991.
5. Bannerman, T.L., Rhoden, D.L., McAllister, S.K., et al. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmo. 115:357-361, 1997. (Pubitemid 27131302)
6. Maylath, F.R., and Leopold, I.H. Study of experimental intraocular infection. I. The recoverability of organisms inoculated into ocular tissues and fluids. II. The influence of antibiotics and cortisone, alone and combined, on intraocular growth of these organisms. Am. J. Ophthalmol. 40:86-101, 1955.
7. Shockley, R.K., Jay, W.M., Fishman, P.H., et al. Effect of inoculum size on the induction of endophthalmitis in aphakic rabbit eyes. Acta Ophthalmol. (Copenh). 63:35-38, 1985.
8. Speaker, M.G., and Menikoff, J.A. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 98:1769-1775, 1991.
9. Ta, C.N., Egbert, P.R., Singh, K., et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology. 109:2036-2040; discussion 2040-12031, 2002. (Pubitemid 35222557)
10. Masket, S. Preventing, diagnosing, and treating endophthalmitis. J. Cataract Refract. Surg. 24:725-726, 1998.
11. Liesegang, T.J. Use of antimicrobials to prevent postoperative infection in patients with cataracts. Curr. Opin. Ophthalmol. 12:68-74, 2001.
12. Ta, C.N., Sinnar, S., He, L., et al. Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora. Eur. J. Ophthalmol. 17:689-695, 2007.
13. Duffey, R.J., and Leaming, D. US trends in refractive surgery: 2004 ISRS/AAO Survey. J. Refract. Surg. 21:742-748, 2005.
14. O'Brien, T.P., Arshinoff, S.A., and Mah, F.S. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J. Cataract Refract. Surg. 33(10):1790- 1800, 2007.
15. Ong-Tone, L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. J. Cataract Refract. Surg. 33:59-62, 2007. (Pubitemid 46001538)
16. Callegan, M.C., Booth, M.C., and Gilmore, M.S. In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens. Cornea. 19:539-545, 2000. (Pubitemid 30460896)
17. Isenberg, S.J., Apt, L., Yoshimori, R., et al. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidoneiodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 103:1340-1342, 1985. (Pubitemid 15230623)
18. Ta, C.N., He, L., Nguyen, E., et al. Prospective randomized study determining whether a 3-day application of ofloxacin results in the selection of fluoroquinolone-resistant coagulase-negative Staphylococcus. Eur. J. Ophthalmol. 16:359-364, 2006. (Pubitemid 44049276)
19. Mino de Kaspar, H., Koss, M.J., He, L., et al. Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am. J. Ophthalmol. 139:730-733, 2005.
20. Kowalski, R.P., Romanowski, E.G., Mah, F.S., et al. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am. J. Ophthalmol. 140:497-504, 2005.
21. Espiritu, C.R., Caparas, V.L., and Bolinao, J.G. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J. Cataract Refract. Surg. 33:63-68, 2007.
22. Barry, P., Seal, D.V., Gettinby, G., et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J. Cataract Refract. Surg. 32:407-410, 2006. (Pubitemid 44313820)
23. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J. Cataract Refract. Surg. 33:978-988, 2007.